Great West Life Assurance Co. Can acquired a new stake in Cantel Medical Corp. (NYSE:CMD) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 52,671 shares of the company’s stock, valued at approximately $4,105,000. Great West Life Assurance Co. Can owned 0.13% of Cantel Medical Corp. at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of CMD. US Bancorp DE acquired a new stake in shares of Cantel Medical Corp. during the second quarter valued at $249,000. Legato Capital Management LLC acquired a new stake in shares of Cantel Medical Corp. during the second quarter valued at $631,000. First Quadrant L P CA acquired a new stake in shares of Cantel Medical Corp. during the second quarter valued at $233,000. Aperio Group LLC acquired a new stake in shares of Cantel Medical Corp. during the second quarter valued at $999,000. Finally, Louisiana State Employees Retirement System acquired a new stake in shares of Cantel Medical Corp. during the second quarter valued at $1,153,000. 83.66% of the stock is currently owned by institutional investors.

Shares of Cantel Medical Corp. (NYSE:CMD) opened at 76.57 on Thursday. The company has a market cap of $3.18 billion, a PE ratio of 45.31 and a beta of 1.23. Cantel Medical Corp. has a 52 week low of $68.19 and a 52 week high of $88.81. The company has a 50 day moving average of $75.76 and a 200 day moving average of $76.82.

Cantel Medical Corp. (NYSE:CMD) last released its earnings results on Thursday, June 8th. The company reported $0.51 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.51. Cantel Medical Corp. had a net margin of 9.50% and a return on equity of 17.75%. The company had revenue of $192.10 million for the quarter, compared to analyst estimates of $193.84 million. The business’s quarterly revenue was up 10.6% on a year-over-year basis. On average, analysts expect that Cantel Medical Corp. will post $2.06 EPS for the current year.

The firm also recently announced a semiannual dividend, which was paid on Monday, July 31st. Investors of record on Monday, July 17th were issued a dividend of $0.07 per share. This represents a dividend yield of 0.18%. The ex-dividend date was Thursday, July 13th. Cantel Medical Corp.’s dividend payout ratio is currently 8.28%.

ILLEGAL ACTIVITY NOTICE: This story was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/08/17/great-west-life-assurance-co-can-invests-4-11-million-in-cantel-medical-corp-cmd.html.

Several analysts recently weighed in on the stock. Needham & Company LLC reissued a “hold” rating on shares of Cantel Medical Corp. in a research note on Thursday, June 8th. Zacks Investment Research cut shares of Cantel Medical Corp. from a “hold” rating to a “sell” rating in a research note on Monday, June 5th. Benchmark Co. cut shares of Cantel Medical Corp. from a “buy” rating to a “hold” rating in a research note on Friday, June 9th. Finally, Sidoti raised shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price objective on the stock in a research note on Wednesday, August 2nd. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $91.67.

In related news, Chairman Charles M. Diker sold 13,000 shares of the stock in a transaction on Monday, June 12th. The shares were sold at an average price of $76.36, for a total transaction of $992,680.00. Following the transaction, the chairman now owns 3,124,222 shares of the company’s stock, valued at approximately $238,565,591.92. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Chairman Charles M. Diker sold 35,000 shares of the stock in a transaction on Wednesday, July 12th. The shares were sold at an average price of $75.52, for a total transaction of $2,643,200.00. Following the transaction, the chairman now directly owns 3,114,520 shares in the company, valued at approximately $235,208,550.40. The disclosure for this sale can be found here. 14.90% of the stock is currently owned by company insiders.

About Cantel Medical Corp.

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Want to see what other hedge funds are holding CMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).

Institutional Ownership by Quarter for Cantel Medical Corp. (NYSE:CMD)

Receive News & Stock Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related stocks with our FREE daily email newsletter.